Chemical Structure : MLi-2
CAS No.: 1627091-47-7
货号: PC-42142Not For Human Use, Lab Use Only.
MLi2 is a potent, selective, orally available and brain-penetrant LRRK2 inhibitor with kinase IC50 of 0.76 nM, cellular IC50 of 1.4 nM (dephosphorylation of LRRK2 pSer935 LRRK2).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥1880 | In stock | |
25 mg | ¥3180 | In stock | |
50 mg | ¥5280 | In stock | |
100 mg | ¥8980 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MLi2 is a potent, selective, orally available and brain-penetrant LRRK2 inhibitor with kinase IC50 of 0.76 nM, cellular IC50 of 1.4 nM (dephosphorylation of LRRK2 pSer935 LRRK2).
MLi2 displays >295-fold selectivity for over 300 kinases in addition to a diverse panel of receptors and ion channels.
MLi2 signficantly reduces the ratio of phosphorylated Ser935 LRRK2 (pS935) to total LRRK2 in the mouse cortex, consistent with enlarged type II pneumocytes.
分子量 | 379.4555 | |
分子式 | C21H25N5O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 26 mg/mL |
|
Chemical Name/SMILES |
1H-Indazole, 3-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-, rel- |
1. Scott JD, et al. J Med Chem. 2017 Apr 13;60(7):2983-2992.
2. Fell MJ, et al. J Pharmacol Exp Ther. 2015 Dec;355(3):397-409.
3. Volpicelli-Daley LA, et al. J Neurosci. 2016 Jul 13;36(28):7415-27.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright